NLINKN1 Chip+PRIME.StudySYNCRStentrode+$75M.SeriesDPRECNLayer 7+FDA.BrkthruPARAMArgo+$20M.SeriesBBLKRKNeuroport+200.ImplantsEMTIVMN8+$45M.SeriesBKRNLFlux+Non-invasiveNRBLEHalo+Consumer.BCINEURONeuroPace+RNS.SystemCOGNICognixion+ALS.TrialFUND.YTD2026$2.8B.SectorTRIALSActive50+.ClinTrialsIMPLNTSHumans~100.Intracrtnl
activeFounded 2015

BrainCo

HQ: Hangzhou, China (US office: Somerville, MA, USA)CEO: Han Bicheng (founder / CEO)Headcount: ~200www.brainco.cn
Funding Summary
Total Funding
$370M
Latest Valuation
$1.3B+ (pre-IPO 2026)
About

BrainCo is China's leading non-invasive BCI company, incubated at the Harvard Innovation Lab and founded by Han Bicheng during his PhD at the Harvard Center for Brain Science. The company develops BCI-controlled bionic prosthetics and cognitive training devices. BrainCo completed a CNY 2B ($286M) financing round in 2025, the largest BCI funding globally outside of Neuralink. The company is preparing for a potential IPO in Hong Kong or mainland China at a $1.3B+ valuation. BrainCo's bionic hands enable amputees to write, type, and perform complex tasks using non-invasive neural signal interpretation. The company also operates BrainRobotics, its prosthetics subsidiary.

Products
brainco-bionic-handbrainco-focus-1brainco-kneuro
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →